IHC of paraffin-embedded Adenocarcinoma of Human endometrium tissue using anti-DNAJA2 mouse monoclonal antibody. (Dilution 1:50).
IHC of paraffin-embedded Human lymphoma tissue using anti-DNAJA2 mouse monoclonal antibody. (Dilution 1:50).
IHC of paraffin-embedded Human lymph node tissue using anti-DNAJA2 mouse monoclonal antibody. (Dilution 1:50).
IHC of paraffin-embedded Carcinoma of Human bladder tissue using anti-DNAJA2 mouse monoclonal antibody. (Dilution 1:50).
IHC of paraffin-embedded Adenocarcinoma of Human ovary tissue using anti-DNAJA2 mouse monoclonal antibody. (Dilution 1:50).
IHC of paraffin-embedded Carcinoma of Human thyroid tissue using anti-DNAJA2 mouse monoclonal antibody. (Dilution 1:50).
IHC of paraffin-embedded Adenocarcinoma of Human breast tissue using anti-DNAJA2 mouse monoclonal antibody. (Dilution 1:50).
IHC of paraffin-embedded Human Kidney tissue using anti-DNAJA2 mouse monoclonal antibody. (Dilution 1:50).
Anti-DNAJA2 mouse monoclonal antibody immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY DNAJA2.
Western blot of extracts (35 ug) from 9 different cell lines by using anti-DNAJA2 monoclonal antibody.
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY DNAJA2 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-DNAJA2.
HEK293T cells transfected with either overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-DNAJA2 antibody, and then analyzed by flow cytometry.